Table 4 Results of the mixed logistic regression predicting for which cases more than one option was recommended (N = 185 cases in 28 sessions)

Dermatological vs. gyn. MDTM

0.95

0.01 to 93.97

.981

Gastrointestinal vs. gyn. MDTM

288.58

0.28 to >999.00

.109

7.36

1.38 to 39.35

.020**

Head and neck cancer vs. gyn. MDTM

1.94

0.17 to 22.07

.593

Liver and biliary tract vs. gyn. MDTM

1.99

0.20 to 19.57

.552

Lymphoma and myeloma vs. gyn. MDTM

4.85

0.17 to 135.52

.351

Neuro-oncological vs. gyn. MDTM

2.81

0.12 to 68.75

.524

5.39

1.24 to 23.45

.025**

Non-entity-specific oncological vs. gyn. MDTM

5.45

0.08 to 386.63

.433

Non-entity-specific surgical vs. gyn. MDTM

14.44

0.29 to 730.38

.181

Thorax vs. gyn. MDTM

1.28

0.00 to >999.00

.944

Uro-oncological vs. gyn. MDTM

21.27

0.31 to >999.00

.154

Number of attending professionals (1 person increase)

0.90

0.71 to 1.13

.352

Duration of session (10 min increase)

0.82

0.36 to 1.84

.630

Number of cases discussed in this session (1 case increase)

1.20

0.82 to 1.76

.347

Quality of case history^a

0.64

0.02 to 26.76

.813

Quality of radiological information^a

0.74

0.39 to 1.41

.359

Quality of information on comorbidities^a

1.12

0.79 to 1.59

.532

Presentation of whether case was palliative (dichotomous variable)

0.52

0.11 to 2.42

.399

Quality of psychosocial information^a

0.95

0.57 to 1.60

.836

Quality of information on the patient’s views and preferences^a

1.10

0.72 to 1.69

.661

Number of active participants in the discussion of each individual case (1 person increase)

0.89

0.60 to 1.33

.571

Quality of chair behavior^a

1.24

0.68 to 2.26

.704

Quality of team behavior^a

1.32

0.58 to 3.01

.508

Medical and treatment uncertainty during case discussion^a

2.12

1.39 to 3.23

.001**

2.16

1.48 to 3.14

<.001**

Duration of case discussion (1 min increase)

1.13

0.94 to 1.43

.203